TY - JOUR
T1 - The effect of midazolam or lidocaine administration prior to etomidate induction of anesthesia on heart rate, arterial pressure, intraocular pressure and serum cortisol concentration in healthy dogs
AU - Keating, Stephanie CJ
AU - Sage, Adrianna M.
AU - Ambrisko, Tamas D.
AU - Somrak, Amy
AU - Carroll, Meredith Q.
AU - Oba, Patricia M.
AU - Martins, Bianca
AU - Swanson, Kelly S.
N1 - Publisher Copyright:
© 2019 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia
PY - 2020/3
Y1 - 2020/3
N2 - Objective: To evaluate selected effects of midazolam or lidocaine administered prior to etomidate for co-induction of anesthesia in healthy dogs. Study design: Prospective crossover experimental study. Animals: A group of 12 healthy adult female Beagle dogs. Methods: Dogs were premedicated with intravenous (IV) butorphanol (0.3 mg kg–1), and anesthesia was induced with etomidate following midazolam (0.3 mg kg–1), lidocaine (2 mg kg–1) or physiologic saline (1 mL) IV. Heart rate (HR), arterial blood pressure, respiratory rate (fR) and intraocular pressure (IOP) were recorded following butorphanol, after co-induction administration, after etomidate administration and immediately following intubation. Baseline IOP values were also obtained prior to sedation. Etomidate dose requirements and the presence of myoclonus, as well as coughing or gagging during intubation were recorded. Serum cortisol concentrations were measured prior to premedication and 6 hours following etomidate administration. Results: Blood pressure, fR and IOP were similar among treatments. Blood pressure decreased in all treatments following etomidate administration and generally returned to sedated values following intubation. HR increased following intubation with midazolam and lidocaine but remained stable in the saline treatment. The dose of etomidate (median, interquartile range, range) required for intubation was lower following midazolam (2.2, 2.1–2.6, 1.7–4.1 mg kg−1) compared with lidocaine (2.7, 2.4–3.6, 2.2–5.1 mg kg−1, p = 0.012) or saline (3.0, 2.8–3.8, 1.9–5.1 mg kg−1, p = 0.015). Coughing or gagging was less frequent with midazolam compared with saline. Myoclonus was not observed. Changes in serum cortisol concentrations were not different among treatments. Conclusions and clinical relevance: Midazolam administration reduced etomidate dose requirements and improved intubation conditions compared with lidocaine or saline treatments. Neither co-induction agent caused clinically relevant differences in measured cardiopulmonary function, IOP or cortisol concentrations compared with saline in healthy dogs. Apnea was noted in all treatments following the induction of anesthesia and preoxygenation is recommended.
AB - Objective: To evaluate selected effects of midazolam or lidocaine administered prior to etomidate for co-induction of anesthesia in healthy dogs. Study design: Prospective crossover experimental study. Animals: A group of 12 healthy adult female Beagle dogs. Methods: Dogs were premedicated with intravenous (IV) butorphanol (0.3 mg kg–1), and anesthesia was induced with etomidate following midazolam (0.3 mg kg–1), lidocaine (2 mg kg–1) or physiologic saline (1 mL) IV. Heart rate (HR), arterial blood pressure, respiratory rate (fR) and intraocular pressure (IOP) were recorded following butorphanol, after co-induction administration, after etomidate administration and immediately following intubation. Baseline IOP values were also obtained prior to sedation. Etomidate dose requirements and the presence of myoclonus, as well as coughing or gagging during intubation were recorded. Serum cortisol concentrations were measured prior to premedication and 6 hours following etomidate administration. Results: Blood pressure, fR and IOP were similar among treatments. Blood pressure decreased in all treatments following etomidate administration and generally returned to sedated values following intubation. HR increased following intubation with midazolam and lidocaine but remained stable in the saline treatment. The dose of etomidate (median, interquartile range, range) required for intubation was lower following midazolam (2.2, 2.1–2.6, 1.7–4.1 mg kg−1) compared with lidocaine (2.7, 2.4–3.6, 2.2–5.1 mg kg−1, p = 0.012) or saline (3.0, 2.8–3.8, 1.9–5.1 mg kg−1, p = 0.015). Coughing or gagging was less frequent with midazolam compared with saline. Myoclonus was not observed. Changes in serum cortisol concentrations were not different among treatments. Conclusions and clinical relevance: Midazolam administration reduced etomidate dose requirements and improved intubation conditions compared with lidocaine or saline treatments. Neither co-induction agent caused clinically relevant differences in measured cardiopulmonary function, IOP or cortisol concentrations compared with saline in healthy dogs. Apnea was noted in all treatments following the induction of anesthesia and preoxygenation is recommended.
KW - co-induction
KW - cortisol
KW - dog
KW - etomidate
KW - lidocaine
KW - midazolam
UR - http://www.scopus.com/inward/record.url?scp=85076240737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076240737&partnerID=8YFLogxK
U2 - 10.1016/j.vaa.2019.09.004
DO - 10.1016/j.vaa.2019.09.004
M3 - Article
C2 - 31813669
AN - SCOPUS:85076240737
SN - 1467-2987
VL - 47
SP - 160
EP - 167
JO - Veterinary Anaesthesia and Analgesia
JF - Veterinary Anaesthesia and Analgesia
IS - 2
ER -